Planta Med 2005; 71(5): 399-405
DOI: 10.1055/s-2005-864132
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Discovering COX-Inhibiting Constituents of Morus Root Bark: Activity-Guided versus Computer-Aided Methods

Judith M. Rollinger1 , 5 , Antje Bodensieck2 , Christoph Seger1 , Ernst P. Ellmerer3 , Rudolf Bauer2 , Thierry Langer4 , 5 , Hermann Stuppner1 , 5
  • 1Institute of Pharmacy, Department of Pharmacognosy, Leopold-Franzens University of Innsbruck, Innsbruck, Austria
  • 2Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Karl-Franzens University of Graz, Graz, Austria
  • 3Institute of Organic Chemistry, Leopold-Franzens University of Innsbruck, Innsbruck, Austria
  • 4Institute of Pharmacy, Department of Pharmaceutical Chemistry, Leopold-Franzens University of Innsbruck, Innsbruck, Austria
  • 5Inte:Ligand GmbH, Software-Engineering and Consulting, Maria Enzersdorf, Austria
Further Information

Publication History

Received: July 26, 2004

Accepted: December 29, 2004

Publication Date:
01 June 2005 (online)

Preview

Abstract

The aim of this study was to compare the efficiency of two well known approaches for the discovery of the bioactive principle/s in medicinal plants, namely the activity-guided isolation versus the computer-aided drug discovery by means of virtual screening (VS) techniques. Morus root bark of Morus sp. L. (Moraceae) was selected as application example for the discovery of compounds with anti-inflammatory activity. The two cyclooxygenase isoenzymes COX-1 and COX-2 were chosen as targets and the corresponding pharmacophore models were generated by our research. The activity-guided fractionation of the methanol extract of the root bark resulted in the isolation of nine compounds. Their structures were elucidated by mass spectrometry, 1- and 2-dimensional NMR experiments and identified as moracins B, M, the regioisomers O/P as a mixture, and sanggenons B, C, D, E and O. The COX-1 and COX-2 inhibiting activities of these compounds were established in an enzyme assay and compared with the predicted hits obtained from the VS. Sanggenons C, E, and O, that were tested the first time for an inhibitory effect on COX-1 and -2, showed IC50 values of 10 - 14 μM, and 40 - 50 μM, respectively. The results show that the COX activities obtained for the sanggenons are correctly predicted by the in silico filtering experiment. In the case of the isolated moracins, however, it failed because the COX inhibiting activities of moracins M and P/O were not retrieved by the VS. Structure-activity relationships of the isolated compounds are discussed as well as potential pitfalls and advantages of the applied strategies.

Abbreviations

COX:cyclooxygenase

EIA:enzyme immunoassay

HBA:hydrogen bond acceptor

PGE:prostaglandin-E

PGHS:prostaglandin-H synthase

VS:virtual screening

References

Dr. Mag. pharm. Judith Maria Rollinger

Institut für Pharmazie

Leopold-Franzens-Universität Innsbruck

Innrain 52

Josef-Moeller Haus

6020 Innsbruck

Austria

Phone: +43-512-507-5308

Fax: +43-512-507-2939

Email: judith.rollinger@uibk.ac.at